newsfilter
← Latest News
GlobeNewswire·

Finch Therapeutics Announces Additions to Senior Leadership Team

Bryan Gillis, MBA, appointed Chief Technology Officer Alka Batycky, PhD, appointed Chief Development Officer Howard Franklin, MD, MBA, appointed Senior Vice President, Late-Stage Development and GI Therapeutic Area Lead SOMERVILLE, Mass., Feb. 10